Kyverna Therapeutics, Inc. Common Stock (KYTX)
US$ 2.60%
Price Chart
Key Statistics
Market Cap
$ 119.72M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
260.76K
52W High
$ 11.40
52W Low
$ 1.78
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
2.6096
200-Day MA
3.5985
52 Week High
11.4
52 Week Low
1.78
About KYTX
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
Employees
119
Headquarters
Emeryville, CA
CEO
Mr. Warner Biddle
Latest News
Kyverna Therapeutics Announces Appointment of New Chief Financial Officer - PR Newswire
3 days ago • Google News
East Texas man accused in fatal hit-and-run of bicyclist in Titus County arrested - cbs19.tv
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg